This Company’s AI Pivot the Street Keeps Mispricing

Wall Street wrote this one off. The setup forming now could catch everyone off guard.

August 24, 2026

A software company that got left for dead two years ago has rebuilt its entire platform around AI-driven contract intelligence. Earnings hit September 3, the chart is the tightest it's been in months, and the buyback keeps chewing through shares in the background.

Golden Dawn Explained (Sponsored)

The name is "Golden Dawn."

That's what President Trump's team is calling America's new Manhattan Project — but for AI.

It will span more than 700 miles — making it by far the largest AI infrastructure project ever built.

When Trump flips the on switch, Louis Navellier believes it will trigger a $100 trillion reset of the AI markets.

For investors who get ahead of it, the timing could mean everything.

Louis' revealing the one stock at the center of it all right here.

*This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.

A software company that got left for dead two years ago has rebuilt its entire platform around AI-driven contract intelligence. Earnings hit on September 3, the chart is the tightest you've seen in months, and the buyback keeps chewing through shares in the background.

DocuSign (NASDAQ: DOCU) cratered in 2022 when growth fell off a cliff, from 50% down to single digits. The Street wrote the obituary and moved on.

What you likely missed is that management spent the last two years rebuilding the product from scratch, and the new platform is closing deals faster than the old one ever did. Q2 FY27 lands after the close on Thursday, September 3.

Look past the tired "e-signature commodity" narrative that killed the stock three years ago. What you find is a company that pivoted into AI-powered contract intelligence before the market cared to notice.

Action: Accumulate between $59 and $63 ahead of Q2 FY27 earnings on September 3. Add on a print that confirms the IAM platform is accelerating.

The IAM Pivot the Models Missed

Intelligent Agreement Management, or IAM, moved from beta to core revenue driver in under 18 months. That's a big deal.

On last quarter's call, management flagged it as the fastest-adopted product they've ever launched, with roughly 40,000 customers now investing in the IAM platform, per management's Q1 FY27 call.

Billings growth turned positive again after a brutal stretch. Dollar-based net retention has stabilized. Free cash flow conversion is running north of 30% of revenue: $289.4 million of free cash flow on $830.2 million of revenue last quarter.

This isn't a moonshot. It's a cash-generative software business that traded at 25x forward sales in 2021 and now trades at roughly 3.6 times forward sales. The math has changed. The narrative hasn't caught up.

Power Trail Emerge (Sponsored)

SpaceX’s S-1 gave investors a closer look at the numbers behind the story.

One detail now getting attention: power demand.

As analysts trace the supply chain behind that demand, Dylan Jovine says one little-known company could be positioned near the center of it.

See the supplier the S-1 may point to.

Trivia: Meta Platforms went through one of the most dramatic corporate turnarounds in recent tech history. What did Mark Zuckerberg call 2023, after two brutal years of layoffs and restructuring?

Login or Subscribe to participate in polls.

What DocuSign Actually Sells Now

You sign a contract, they process it. That's the surface layer.

The real business is what happens after the signature: routing, storage, obligation tracking, renewal alerts, and integration with Salesforce and Workday. IAM turns each executed agreement into structured data that AI can read, search, and act on.

Think Bloomberg terminals for legal documents. Once a customer is on IAM, pulling them out hurts. Switching costs are high, integrations are sticky, and every new AI feature widens the moat. That's why writing this off as a commodity signature app was the wrong call.

AI Warning Issued (Sponsored)

AI insider Keith Kaplan says the next phase of the AI boom could punish investors who are still crowded into the biggest names.

After spending more than $17 million on AI research, he says there’s one move investors should consider before August 31 — and it doesn’t involve Nvidia, SpaceX, or Microsoft.

Reveal the AI Move Keith Says to Make Before August 31.

Three Reasons the Setup Is Different This Time

The AI agreement thesis has legs. Agreements are the last unstructured dataset in your enterprise stack. Salesforce structured customers. Workday structured people.

DocuSign is structuring the contracts that govern both. Once you see IAM pulling out obligations and renewal dates automatically, the ROI conversation gets short.

The buyback is shrinking the float. Docusign repurchased $318 million of stock in Q1 FY27, its largest quarterly buyback ever, and that pulled diluted share count down 8% to 196.5 million. Fewer shares means every dollar of earnings growth gets multiplied on a per-share basis.

Enterprise deal sizes are trending up. Legacy DocuSign sold seat-based signatures. IAM sells enterprise platform contracts, and those land at multiples of the old ACVs. That mix shift alone can turn your 6% grower into a low-teens grower without a single new logo.

Action: Track the IAM adoption commentary in the Q2 FY27 release. If management drops an ARR contribution number, that alone reprices the stock.

Reading the Financials

Trailing twelve-month free cash flow runs north of $1 billion, which funds the buyback, feeds AI investment, and keeps the balance sheet clean. You aren't paying for growth here. You're getting paid to wait for it.

Billings is the leading indicator in SaaS, not revenue.

Management guided Q2 revenue to $865 million to $869 million, about 8% growth, so billings running ahead of that pace is what makes your reacceleration story real. If not, your thesis takes a hit. Watch that single number more than the headline EPS.

Non-GAAP operating margin hit 32% last quarter, and management guided the full year to 30.5% to 31%. Every 100 basis points of margin on a business this size drops meaningfully to the bottom line.

Action: Anchor your reaction to billings and IAM commentary, not the EPS headline. Algos will fixate on EPS. You shouldn't.

Bear Case

Multiple compression cuts both ways. The stock traded at 25x sales in 2021 and trades at a fraction of that today. Good news, mostly. The bad news: if IAM traction disappoints, you have no premium multiple to fall back on.

You also need to accept that the multiple stays depressed until IAM revenue gets broken out separately. Until management gives that disclosure line, the Street treats this as a legacy SaaS name and refuses to pay up, and your upside comes from earnings rather than a re-rating.

Startups are building AI-first contract tools and pricing below DocuSign. If IAM's premium features don't justify the gap, churn ticks up and the thesis wobbles.

CIOs are consolidating vendors and stretching evaluations. If macro gets worse, big IAM deals slip a quarter and the reacceleration story gets pushed out.

Key-person risk. Allan Thygesen has run Docusign since October 2022 and the IAM pivot is his. Any C-suite churn in the middle of a platform transition would rattle sentiment fast.

Action: Hedge with a broader software basket like the iShares Expanded Tech-Software ETF (IGV) if you want IAM exposure without single-name headline risk. If you're growth-focused, pair this with a smaller AI-native contract play if one goes public.

Catalysts on the Calendar

Q2 FY27 earnings after the close on Thursday, September 3.

Watch for IAM customer count above the 40,000 reported in Q1, billings growth ahead of the 8% revenue guide, and any specific IAM revenue contribution number. Management guiding IAM revenue for FY27 would be a meaningful catalyst on its own.

Any analyst day or investor update where management commits to a medium-term IAM revenue target. That gives the sell side something to model, and models are what drive the multiple.

Continued buyback execution. If share count keeps ticking down each quarter, EPS grows even at flat revenue. Watch for the authorization to get refreshed before it runs out.

How I'd Play It

Take a half-size position at current levels ahead of the print. You get exposure without betting the whole thesis on one number.

Add on a beat, or on a dip below $59 that isn't tied to a business change. Don't chase a post-earnings gap.

If you already own it, hold through the print. The setup is asymmetric. A miss is more priced in than a beat.

Setup Scorecard

Entry Zone: $59–$63

Target: $71

Stop Loss: $55

Catalyst Timeline: Q2 FY27 earnings on September 3, potential analyst day in Q4, continued buyback execution each quarter

Confidence Level: Medium. The business is cash-generative and the platform pivot is real, but the multiple won't expand until IAM revenue is broken out separately.

The Agreement Platform Wall Street Is Modeling Wrong

Q2 FY27 earnings on September 3 are your near-term catalyst. IAM traction is the medium-term thesis you're paying for.

The buyback keeps working whether the Street pays attention or not. Buy the setup ahead of the print, size it to what you can hold through a miss, and let the reacceleration play out over the next few quarters.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any tech stocks you want me to check out.

Best Regards,
—Noah Zelvis
Tech Stock Insider